1. India Stocks

  2. •

    Process industries

  3. •

    Agricultural commodities/Milling
Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Ltd.

130.52
INR
+0.15
(+0.12%)
20.15EPS
8.64P/E
3.13BMarket Cap
Nath Bio-Genes (India) Ltd.
NSE:NATHBIOGEN
(National Stock Exchange of India)

Recent

price

130.52

P/E

ratio

8.64

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
77.43
86.04
107.55
115.8
101.29
106.09
112.79
121.32
147.28
161.73
146.47
158.58
175.03
192.02
234.21
255.19
Revenue per Share
5.75
7.34
15.19
15.87
8.85
10.17
17.31
20.22
26.56
29.29
-35.46
18.42
20.85
20.31
21.91
19.07
Basic EPS, GAAP
- -
-4.46
7.58
3.26
-12.92
-0.49
-30.51
-23.8
-3.54
-5.52
8.38
18.85
25.16
5.08
-8.2
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
2
2
- -
Dividend per Share
28.57
35.91
51.1
66.94
179.35
189.52
246.91
267.09
293.42
322.71
285.16
301.62
320.94
339.08
358.06
- -
Book Value per Share
19.2
28.64
45.92
63.86
178.08
189.52
244.81
265.2
285.44
315.54
278.84
296.14
316.31
335.3
355.12
- -
Tangible Book Value per Share
16
16
16
16
16
16
17
19
19
19
19
19
19
19
19
19
Basic Weighted Avg Shares
1,239
1,377
1,721
1,853
1,621
1,698
1,916
2,306
2,799
3,073
2,784
3,014
3,326
3,649
4,451
4,898
Sales/Revenue/Turnover
9.85
11.5
16.9
16.46
13.15
15.74
20.96
18.31
19.11
20.97
12.43
15.28
14.08
13.01
11.04
9.25
Operating Margin (%)
47
45
47
44
39
30
10
14
15
28
62
60
65
38
40
40
Depreciation Expense
92
117
243
254
142
163
294
384
505
557
-674
350
396
386
416
366
Net Income, GAAP
- -
4.48
4.74
3.63
6.04
2.81
2.12
1.12
- -
1.92
- -
3.19
4.68
4.89
10.09
10.91
Effective Tax Rate (%)
7.42
8.53
14.12
13.7
8.74
9.59
15.35
16.67
18.04
18.11
-24.21
11.62
11.91
10.58
9.35
7.47
Profit Margin (%)
242
359
542
814
965
1,121
2,544
2,711
3,027
3,631
2,735
3,034
3,092
3,247
3,842
- -
Working Capital
8
12
14
7
150
201
3
5
3
7
7
4
49
130
173
- -
LT Debt
457
575
818
1,071
2,870
3,033
4,692
5,076
5,576
6,133
5,419
5,732
6,099
6,444
6,805
- -
Total Equity
- -
18.1
27.32
25.5
5.98
4.5
8.89
7.82
- -
9.43
- -
6.85
6.92
6.07
6.37
- -
Return on Invested Capital (%)
- -
18.1
31.3
25.51
8.21
6.96
8.9
8.12
- -
9.45
- -
6.74
6.84
6.46
6.98
- -
Return on Capital (%)
- -
22.76
34.91
26.89
7.19
5.52
7.62
7.87
9.48
9.51
-11.67
6.28
6.7
6.15
6.28
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1,212
- -
LT Borrowings
- -
173
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
2,955
2,452
3,131

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
7,789
- -
Cash, Cash Equivalents & STI
- -
2,389
- -
Accounts Receivable, Net
- -
854
- -
Inventories
- -
4,505
- -
Total Current Liabilities
- -
3,947
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,212
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.02%
2.36%
5.6%
Free Cash Flow
593.2%
-86.93%
-261.25%
Net Income, GAAP
-18.67%
-70.92%
7.85%
Sales/Revenue/Turnover
11%
8.18%
21.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2,439
322
369
520
3,649
2026
2,837
438
660
516
4,451
2027
3,284
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
17.49
0.53
1.39
0.78
20.31
2026
14.88
1.4
0.84
- -
21.91
2027
16.98
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
2
2026
- -
- -
- -
- -
2
2027
- -
- -
- -
- -
- -
Similar Companies
Tilray Brands, Inc. (NASDAQ:TLRY)
Archer-Daniels-Midland Company (NYSE:ADM)
Patanjali Foods Limited (NSE:PATANJALI)
Corteva, Inc. (NYSE:CTVA)
Canopy Growth Corporation (NASDAQ:CGC)
Balrampur Chini Mills Ltd (NSE:BALRAMCHIN)
Business
Nath Bio-Genes (India) Limited engages in the research, development, production, processing, and marketing of BT cotton, hybrid, and varietal seeds for field crops, vegetables, oilseeds, fiber crops, and forage; it also offers plant nutrition supplements including WINPro GOLii, WINall, Win Chin Win, WINALL granules, and WINPRO GOLI, as well as forage products such as NUTRIMAX and NUTRIMAX GOLD. The company operates primarily in India through approximately 16 business centers covering 131 territories and over 2,000 distributors, with emerging international presence including a joint venture, Nath Bio-Genes CA LLC in Uzbekistan incorporated in 2025 holding a 90% stake, and advancements in the Philippines; it sources seed production from over 30,000 acres leased from 25,000 growers nationwide. Founded in 1979 as part of the Nath Group by Nandkishor Kagliwal and headquartered in Aurangabad, Maharashtra, Nath Bio-Genes supports farmers via over 500 Nath Farmer Advisors delivering extension services like crop demonstrations, agronomic guidance, and post-harvest training to approximately 200,000 farmers. Recent developments include the launch of four new hybrid paddy varieties, Dhoom, Dhadak, and Dhadak Gold, alongside two new organic fertilizers, WINALL granules and WINPRO GOLI, in 2023-24 to enhance soil nutrition; the company reports robust Q2FY26 financials with 23.5% revenue growth to Rs 398 million, 45.4% profit after tax increase to Rs 42 million, expanded gross margins to 68%, and strong vegetable seeds segment growth of 24.4%, complemented by successful Uzbekistan joint venture operations.